*P<0.05 compared to the healthy controls, **P<0.001 compared to the healthy controls, †P<0.001 compared to the MCNS patients MCNS: Minimal change nephrotic syndrome |
||||||||||||||||||||
Table 2: Semiquantitative immunohistochemical analysis of MAS receptor expression. |